Abstract
Objective
Indexes of brain serotonin2A (5-HT2A) density have never been investigated in a sample of humans with violent aggressive behaviour unbiased by medication use or current axis I psychiatric disorders. The objective of this study was to investigate prefrontal cortex 5-HT2A binding potential (BPND), an index of 5-HT2A density, in an unbiased sample of people with violent aggressive behaviour.
Methods
We used [18F] setoperone positron emission tomography to measure 5-HT2A BPND in the dorsolateral prefrontal cortex (primarily sampling Brodmann area 9) in 16 participants with violent aggressive behaviour and 16 healthy control participants.
Results
In people with violent aggressive behaviours, the slope of 5-HT2A BPND decline in the dorsolateral prefrontal cortex is 44% less than in healthy control participants (analysis of variance group by age interaction, p = 0.004). Prefrontal cortex 5-HT2A BPND was significantly lower in participants with more severe impulsivity and aggression (multiple linear regression with age and Barratt Impulsivity Scale [BIS] as predictor variables and regional 5-HT2A BPND as dependent variable; effect of BIS, dorsolateral prefrontal cortex: F1,13 = 7.95, p = 0.014).
Conclusion
Lower prefrontal 5-HT2A BPND is related to violent aggression. Lower 5-HT2A BPND occurs at a younger age, when violent behaviour is more frequent, and is more prominent when impulsivity and aggression are more severe.
Medical subject headings: aggression; serotonin; receptors, serotonin, 5-HT2A; positron emission tomography; setoperone; suicide
Abstract
Objectif
On n'a jamais étudié les indices de la densité de la sérotonine2A (5-HT2A) dans le cerveau d'un échantillon d'êtres humains qui ont un comportement agressif violent sans distorsion attribuable à l'utilisation de médicaments ou à des troubles psychiatriques courants de l'axe I. Cette étude visait à analyser le potentiel de fixation (BPND) de la 5-HT2A dans le cortex préfrontal, indice de la densité de la 5-HT2A, dans un échantillon sans distorsion de personnes qui avaient un comportement agressif violent.
Méthodes
Nous avons utilisé la tomographie par émission de positrons et la [18F] sétopérone pour mesurer le potentiel BPND de la 5-HT2A dans le cortex préfrontal dorsolatéral (principalement dans l'aire de Brodmann 9) chez 16 participants qui avaient un comportement agressif violent et 16 participants témoins en bonne santé.
Résultats
Chez les personnes qui avaient des comportements agressifs violents, la pente de la diminution du potentiel BPND de la 5-HT2A dans le cortex préfrontal dorsolatéral est inférieure de 44 % à celle des participants témoins en bonne santé (analyse des groupes de variance selon l'interaction en fonction de l'âge, p = 0,004). Le potentiel BPND de la 5-HT2A dans le cortex préfrontal était beaucoup moins élevé chez les participants qui avaient une impulsivité et une agression plus sévères (régression linéaire multiple en fonction de l'âge et échelle de l'impulsivité de Barratt [BIS] comme variables prédictives et potentiel BPND régional de la 5-HT2A comme variable dépendante; effet de la BIS, cortex préfrontal dorsolatéral : F1,13 = 7,95, p = 0,014).
Conclusion
On établit un lien entre le potentiel BPND de la 5-HT2A dans le cortex préfrontal moins élevé et l'agressivité violente. Le BPND moins élevé de la 5-HT2A fait son apparition à un âge plus jeune, lorsque le comportement violent est plus fréquent, et il est plus évident lorsque l'impulsivité et l'agression sont plus sévères.
Introduction
Both neuroimaging and neuropsychological studies suggest that abnormal functioning of structures regulating emotional responses, such as the prefrontal cortex, amygdala and anterior cingulate cortex, increase the risk of developing aggressive violent behaviour.1–4 A prevailing theory regarding the role of serotonin in the neurobiology of violence is that people with impulsive and/or aggressive violent behaviour have lifelong lower extracellular serotonin levels throughout the brain that are functionally relevant in the prefrontal cortex, leading to behavioural disinhibition.1,3,5–7
The main reason for this belief is that the metabolite of serotonin, 5-hydroxyindolacetic acid (5-HIAA), is often low in the cerebrospinal fluid of people with impulsive and aggressive behaviour.5–7 Cerebrospinal fluid (CSF) 5-HIAA has an indirect relation to brain serotonin, so there may be explanations for this finding other than globally low serotonin levels in the brain. For example, low CSF 5-HIAA may be caused by low serotonin metabolism, and this latter abnormality has also been implicated in violent behaviour.8 Therefore, additional investigations are important to corroborate this hypothesis with respect to low extracellular brain serotonin in people with violent behaviour. Investigations of 5-HT2A receptors in people exhibiting violent behaviour may have important implications because 5-HT2A density has an inverse relation to extracellular serotonin levels such that increased 5-HT2A density may occur during chronic 5-HT depletion.9–12
Arora and Meltzer13 reported a relation between suicide using a violent method and elevated frontal cortex 5-HT2A receptor density. In a subsequent review, Mann and colleagues14 observed that investigations of suicide completers that report increased prefrontal cortex 5-HT2A receptor density13,15–18 typically report more violent methods of suicide. A recent psychological autopsy study reported greater aggression and impulsivity in people who die by violent suicide.19 Thus it is possible that these early postmortem human studies of violent suicide support a link between aggression and elevated prefrontal cortex 5-HT2A receptor binding.
Serotonin2A and 5-HT transporter (5-HTT) receptors and tryptophan uptake have been investigated in people with borderline personality disorder.20–22 A study also exists of brain 5-HTT binding in people with aggression and a history of methamphetamine abuse.23 However, there has never been a study specifically investigating whether prefrontal 5-HT2A binding is elevated in people with violent aggressive behaviour that addresses biases of other syndromes and diagnoses. The most definitive study to date of aggression and 5-HT2A receptors in humans focused on people who died by suicide.24 However, in this study, current major depressive disorder was present in the majority of participants who died by suicide (23/37), and current medication use was present in about one-half of the participants who died by suicide (17/37). Both current antidepressant use and being in a major depressive episode are known to influence indices of 5-HT2A receptor density in humans.18,20,25–28 Therefore, it is not clear whether a relation between 5-HT2A receptors and aggression exists after biases such as current major depressive episodes and antidepressant use have been addressed.
The main hypothesis of this study was that prefrontal 5-HT2A receptor binding potential (BPND), as measured with [18F] setoperone positron emission tomography (PET), would be elevated in people who have violent angry behaviours toward others. This hypothesis is based on the more general model of lowered extracellular serotonin throughout the prefrontal cortex in people with violent behaviour.5–7 In such a model, 5-HT2A receptors would be expected to be upregulated secondary to chronically lowered extracellular serotonin levels.9–12 The second hypothesis was that the subset of people with the most severe impulsivity would have the most elevated prefrontal 5-HT2A BPND. The 5-HT2A BPND, an index of 5-HT2A receptor density, can be measured with [18F] setoperone PET.29–31 To address biases of medication use and active axis I disorders, enrolment criteria excluded psychotropic medication use within the previous 6 months and required remission of axis I symptoms for at least 3 months, with the exception of full remission from alcohol abuse, for which a 1-month cut-off was applied. The prefrontal cortex region (focusing on Brodmann area 9) was chosen because this is the region where most of the investigations of suicide completers report elevated 5-HT2A receptor density.13,15–18 If violent angry behaviours are associated with increased prefrontal cortex 5-HT2A receptor density, then prefrontal cortex 5-HT2A BPND, an index that reflects 5-HT2A density, should be increased.
Setoperone shows high selectivity for 5-HT2A receptors in human cortex, as discussed previously.25,32 In the present paper, abnormalities of 5-HT2 receptors in brain cortex are viewed as reflecting abnormalities of 5-HT2A receptors in cortex because available evidence suggests that the density of the other 2 subtypes is very low. In cortex, messenger ribonucleic acid of 5-HT2B receptors is extremely low,33 and binding to 5-HT2C receptors suggests a very low density of these receptors.34
Methods
Participants
This study was approved by the Centre for Addiction and Mental Health Ethical Review Committee at the University of Toronto. We recruited 16 healthy individuals (mean age 29.06, standard deviation [SD] 6.17 yr; 9 men, 7 women) and 16 individuals with histories of violent behaviour, anger dyscontrol and aggression (mean age 29.31, SD 6.26 yr; 10 men, 6 women). The participants ranged in age from 19 to 39 years. All had been free of psychotropic medication for at least 6 months, had no history of neurotoxin use and had good medical health.
Healthy participants were age-matched to within 3 years of violent participants. We screened healthy participants to rule out axis I disorders, using the Structured Clinical Interview for the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV).35 In a structured interview, we also asked healthy individuals questions about suicide attempts, impulsive behaviour, anger dyscontrol problems, alcohol intake and substance abuse to rule out these behaviours.
The 16 participants with anger management and aggression problems were recruited from either the Anger Management Clinic or an advertisement at the Centre for Addiction and Mental Health. The main inclusion criteria were age 18–40 years, good medical health, consistent report over 3 different interviews of repeated, serious, violent behaviour toward others that could not be accounted for by either substance abuse or an axis I disorder (except for intermittent explosive disorder, which was not exclusionary). Table 1 describes the behaviours in terms of frequency and examples of severity. Given the comorbidity of axis I mood and anxiety disorders in patients with aggressive behaviour, patients with a history of major depressive disorder or other axis I illnesses were not excluded provided there was a clear history of violent aggressive behaviour outside the episode of the axis I illness and that the axis I illness was in remission. The exception to this was bipolar disorder I and II, which were both exclusionary.
Table 1
Participants with histories of violent behaviour received the following screening instruments so that we would have detailed clinical information: the Structured Clinical Interview for DSM-IV for axis I disorders,35 the Structured Clinical Interview for DSM-IV for axis II disorders36 and the Scale for Suicidal Ideation.37 The Barratt Impulsiveness Scale, version 11 (BIS)38 and the Buss–Durkee Hostility Inventory (BDHI)39 were chosen as the primary quantitative measures of impulsive behaviour. The BIS is a more general measure of impulsivity, and the BDHI measures a subset of impulsive behaviours related to hostility.38,39 We asked each subject structured questions regarding frequency and method of aggression, including details of temper tantrums (verbal aggression), assaults on others, weapon use and property destruction. The mean BIS score was 69.13 (SD 13.27), and the mean BDHI score was 47.81 (SD 12.97). All participants with a history of violent behaviour had a diagnosis of antisocial personality disorder and/or conduct disorder. Ten participants had a history of one or more of the following axis I disorders: major depressive disorder (n = 4), generalized anxiety disorder (n = 1), obsessive–compulsive disorder (n = 1), dysthymic disorder (n = 1), alcohol abuse (n = 5) and substance abuse (n = 4). However, in all participants, the axis I disorders were in full remission. For the 4 participants with past substance abuse, 2 abused cannabis, 1 abused benzodiazepines and 1 abused both heroin and cocaine. The first 3 of these participants were also in the group who had histories of alcohol abuse. Four participants had current suicidal ideation, and 2 participants had a history of attempting suicide. In addition to having either antisocial personality disorder and/or conduct disorder, 5 participants also met criteria for a different axis II disorder: 2 for paranoid personality disorder, 1 for borderline personality disorder, 1 for histrionic personality disorder and 1 for obsessive–compulsive disorder. Urine drug screening was done for all participants with a history of violence. All patients received common blood tests to rule out medical causes of disturbed mood (thyroid function, electrolytes and complete blood cell count).
Image acquisition and analysis
An intravenous bolus of 185 MBq of [18F] setoperone29,31 was injected. PET images were obtained with a GEMS 2048–15B camera (intrinsic in-plane resolution, full width at half maximum 5.5 mm; Scanditronix Medical, General Electric); [18F] setoperone had high radiochemical purity (> 99%) and high specific activity (44, SD 39 GBq/μmol at the time of injection). Images were obtained in five 1-minute frames, followed by seventeen 5-minute frames. The images were corrected for attenuation with the use of a 68Ge transmission scan and were reconstructed by filtered back projection (Hanning filter).
The kinetics of [18F] setoperone can be described with a 3-tissue compartment model in regions with specific binding and a 2-tissue compartment model in the reference region.30,31 The kinetics of [18F] setoperone are fast in humans, with peak uptake in regions of specific binding, typically between 10 and 20 minutes. Traditionally, reference tissue methods have been suitable for [18F] setoperone, and this has previously been partially discussed.20,28,32 For 3 reasons, we used the simplified reference tissue model, version 2 (SRTM2).40 It is sensitive to the age-related decline in 5-HT2A BPND. It does not underestimate 5-HT2A BPND, and it obtains highly reliable measurement. We used this method for our previously published reliability data sets41 and found it had similarly excellent reliability. The mean absolute difference in 5-HT2A BPND, expressed as a percentage of 5-HT2A BPND, was less than 6%. We also applied the Logan method. Although it has a modest underestimate of 5-HT2A BPND, it is similarly reliable and is also sensitive to age-related decline.42
Because this is the first investigation of 5-HT2A receptors in a sample of people with aggressive behaviour and no active axis I disorders, we could not refer to previous studies of 5-HT2A receptors in precisely the same sample to guide the selection of regions of interest (ROIs). However, we applied several criteria based on related investigations. Because a subset of suicide victims may have violent behaviour, our highest priority was to review studies of suicide victims and choose regions reported to have elevations in 5-HT2 receptor binding.13,15–18,27,43 Consequently, the primary ROI was a bilateral region of the middle frontal gyrus that mainly sampled Brodmann area 9. Our second criterion was to select regions in which abnormal function was found to be associated with impulsive, aggressive behaviours; this led us to select the orbitofrontal cortex (Brodmann areas 47 and part of 11).3,4,44 The third criterion was to choose regions sampled in our other published studies of 5-HT2A receptor binding in major depressive disorder and borderline personality disorder20 so that measures would be consistent across different patient samples. Therefore, we included the posterior medial temporal gyrus (Brodmann areas 20 and 21) and anterior cingulate (Brodmann areas 24 and part of 32) regions.
We found these ROIs by using a semiautomated method20 verified by visual assessment with reference to a coregistered magnetic resonance imaging scan (General Electric Signa 1.5T scanner, spin-echo sequence proton density weighted image; x, y, z voxel dimensions 0.78, 0.78 and 3 mm, respectively). The reference tissue was a sampling of posterior cerebellar cortex that omitted the vermis and the white matter and avoided venous sinuses and occipital cortex by 6 mm. These methods have been previously described in more detail.20
Statistical analysis
The primary hypothesized ROI was the dorsolateral prefrontal cortex; however, we undertook similar analyses for each cortex region. The main analyses focused on prefrontal cortex 5-HT2A BPND and violent aggressive behaviour. First, we compared the age-related decline in regional cortex 5-HT2A BPND in participants exhibiting violent behaviour with that in control participants. Using an analysis of covariance (ANCOVA) with age as a covariate, we examined the interaction between age and group. We then compared regional cortex 5-HT2A BPND between groups, applying the Johnson– Neyman technique. Finally, we assessed the association between regional cortex 5-HT2A BPND and severity of impulsivity and aggression by applying an ANCOVA with 5-HT2A BPND as the dependent variable and age and BIS score as predictor variables.
Results
We obtained similar results in each region regardless of whether we used the SRTM2 method40 or the Logan method.42 For regional 5-HT2A BPND values in the sampled participants, the correlation coefficient between the 2 methods was between 0.92 and 0.99 for every region. For each analysis, we present the results obtained with the SRTM2 method and then comment on whether the results are similar to those obtained with the Logan method.
Relation of violent aggressive behaviour and age to cortex 5-HT2A BPND
Serotonin2A BPND declined linearly with age in both groups. However, there was a considerably slower rate of decline in cortex 5-HT2A BPND in the group with violent aggression, compared with the control group (dorsolateral prefrontal cortex: –0.046/yr in the violent group; –0.081/yr in the control group; 44% difference) (Fig. 1 and Table 2). This differential age effect was statistically significant (ANCOVA interaction between age and group, F1,28 = 9.86, p = 0.004). Similar results were found in other regions, where the difference in age-related 5-HT2A BPND decline ranged from 44% to 53% (ANCOVA interaction between age and group, F1,28 = 4.24–13.52, p = 0.049–0.001 (Fig. 1 and Table 2). Even after the application of a partial volume correction method,45 the age-dependent difference in prefrontal 5-HT2A BPND remained significant (ANCOVA interaction between age and group, F1,28 = 8.70, p = 0.006). We expected some reduction in the level of significance because partial volume correction methods tend to increase variance.
Fig. 1: Relation between regional cortex serotonin2A (5-HT2A) binding potential [BPND]) and age in participants with violent behaviour compared with nonviolent healthy control participants There was a significant interaction between age and diagnosis for each region (analysis of covariance, interaction between age and diagnosis, dorsolateral prefrontal cortex: F1,28 = 9.86, p = 0.004; orbitofrontal cortex: F1,28 = 13.52, p = 0.001; rostral anterior cingulate cortex: F1,28 = 4.24, p = 0.049; posteromedial temporal cortex: F1,28 = 10.54, p = 0.003).
Table 2
Moreover, for this specific sample, it did not seem necessary to apply partial volume correction because there was no significant between-group difference in whole prefrontal cortex ROI volume (t30 = –0.66, p = 0.52, 2% difference).
A recent report found that cortex 5-HT2A BPND was elevated in individuals with a history of recurrent major depressive episodes (MDE).46 In the present study, there were 4 participants in the violent group who had histories of a single MDE only. Although it is possible that participants with a single previous MDE are different from those with multiple previous MDEs, we performed a subanalysis excluding the 4 participants with a history of MDE. Excluding these 4 participants from the violent group did not alter the rates of age-related decline in 5-HT2A BPND (the slopes remained similar). Moreover, the differences in the slope of the age-related decline between this subgroup of violent participants and the healthy control group were similarly significant for every region (differences ranged from 41% to 63%, F1,24 = 5.57–17.12, p = 0.03–0.0004)
Comparison of regional 5-HT2A BPND between groups
Because the slopes of the age-related decline were different, we applied the Johnson–Neyman technique to consider the differences between groups with respect to age. For almost all the analyses of all regions, cortex 5-HT2A BPND was significantly lower in the group with violent behaviour than in control participants at age 19 years, similar to that in control participants at age 29 years and significantly higher than in control participants at age 39 years (see Table 3). The exception was the analysis for the rostral anterior cingulate region when the SRTM2 method was used.
Table 3

Relation between impulsivity, aggression and cortex 5-HT2A BPND
Our primary quantitative measures of impulsive behaviour were the BIS38 and the BDHI.39 In this sample, the total values of these 2 measures were highly intercorrelated (Pearson correlation coefficient, r = 0.66, p = 0.006). Cortex 5-HT2A BPND scores were strongly associated with BIS scores such that lower 5-HT2A BPND was associated with more severe impulsivity (Fig. 2.) Multilinear regression using age and BIS score as predictor variables and regional 5-HT2A BPND as the dependent variable, the effect of BIS was as follows: dorsolateral prefrontal cortex, F1,13 = 7.95, p = 0.014; orbitofrontal cortex, F1,13 = 7.48, p = 0.017; rostral anterior cingulate cortex, F1,13 = 8.34, p = 0.013; posteromedial temporal cortex, F1,13 = 5.43, p = 0.037. We obtained similar results for all analyses with the Logan method.42 Even after we applied a partial volume correction method,45 the correlation between the BIS scores and prefrontal 5-HT2A BPND remained. There was no significant correlation between prefrontal cortex ROI volume and BIS score or between BIS scores and age.
Fig. 2: In people with violent behaviour, lower regional cortex serotonin2A (5-HT2A) binding potential [BPND]) is associated with more severe impulsivity. Cortex 5-HT2A BPND scores were strongly associated with Barratt Impulsiveness Scale (BIS) scores such that lower 5-HT2A BPND was associated with more severe impulsivity (analysis of covariance, age and BIS as covariates, regional 5-HT2A BPND as dependent variable, effect of BIS, dorsolateral prefrontal cortex: F1,13 = 7.95, p = 0.014; orbitofrontal cortex: F1,13 = 7.48, p = 0.017; rostral anterior cingulate cortex: F1,13 = 8.34, p = 0.013; posteromedial temporal cortex: F1,13 = 5.43, p = 0.037). For the above figure, age-normalized 5-HT2A BPND values to age 20 are shown. Age-normalized values were calculated by taking the difference between the individual subject age and the age normalized to slope (m) of the age-related decline in 5-HT2A BPND (normalized 5-HT2A BPND = raw 5-HT2A BPND + diff*m).
Post hoc analyses showed a trend between the BIS score38 and the Scale for Suicidal Ideation37 (r = 0.46, p = 0.07) and a significant correlation between the BDHI39 and the Scale for Suicidal Ideation37 (r = 0.57, p = 0.02).
Discussion
This study is the first prospectively designed investigation of 5-HT2A receptors in people with violent aggressive behaviour toward others wherein the participants do not have major biasing influences on 5-HT2A receptors, such as medication use or active axis I psychiatric illnesses. We did not find an elevation in prefrontal cortex 5-HT2A BPND at all ages. Instead, we found that cortex 5-HT2A BPND is different in this group, being lower around age 20 years and higher at ages 35–40 years, compared with control participants. We also found a strong relation between severity of impulsive behaviour and cortex 5-HT2A BPND in that 5-HT2A BPND is lower when impulsive behaviours are more severe. These findings have important implications for the neurochemical model of human aggressive behaviour, for our understanding of whether 5-HT2A receptor abnormalities are specific to diagnosis or suicide and for the practice of reducing violent behaviour with selective serotonin reuptake inhibitors (SSRIs).
We interpret lower prefrontal cortex 5-HT2A BPND to be related to violent aggressive behaviour because lower 5-HT2A BPND correlated with greater severity of impulsivity and aggression. In addition, lower 5-HT2A BPND tended to occur at younger ages, which became evident when we evaluated the subject data at age 19 years. The comparison between violent and nonviolent groups is dependent on the age chosen, and we felt that the result at age 19 years was most relevant for this comparison because repeated impulsive and violent behaviour typically starts in the teenage years and almost always starts before the midtwenties.47 For this interpretation, we applied the traditional strategies in neurologic and psychiatric illness research to understand the connection between brain pathology and symptoms: observed brain abnormalities are considered in relation to the symptoms that start or are highly prevalent at the time of the abnormality. A lower prefrontal cortex 5-HT2A BPND in the violent aggressive group was opposite to the hypothesis; however, it is consistent with a recent set of studies demonstrating that mice whose prefrontal cortex 5-HT2A receptors have been removed show decreased avoidance of risk-laden behaviours.48
Earlier investigations in humans often report lower CSF 5-HIAA in people with aggressive behaviour.5–7 Lower CSF 5-HIAA can support several neurochemical models of aggression, including low brain 5-HT (both intracellular and extracellular), reduced 5-HT conversion to 5-HIAA8 and general loss of neurons.49–51 The results of the present study could be interpreted as being unsupportive of the first model. Cortex 5-HT2A receptors typically show an inverse relation to extracellular 5-HT levels; that is, they increase in density when extracellular 5-HT is low.9,10 If 5-HT2A receptors regulate normally in people with violent behaviour, then low cortex 5-HT2A BPND is unlikely to support a human model of low extracellular 5-HT in the cortex. To have low cortex 5-HT2A BPND at the same time as low extracellular 5-HT in the cortex, there should be either fewer cells present that express 5-HT2A receptors or an abnormal regulation of these receptors relative to extracellular 5-HT levels. Future investigations are needed to ascertain which model best applies, but there is reason to reconsider the concept that low CSF 5-HIAA is the equivalent of low extracellular 5-HT in the prefrontal cortex in people with violent behaviour.
The results of this study differ from those of previous studies that sampled people who died by violent suicide. One possible reason is that the participants in the present study reported violent behaviour toward others, whereas in earlier studies, violent behaviour was the method of suicide.13,15–18,26 A violent method of suicide need not always imply violent behaviour toward others at different times of life. A second possible reason for the difference between our study results and those of previous studies of violent suicide victims is that our sample was younger than most of the previous samples. Most samples in earlier, postmortem investigations of suicide had mean ages in the range of 35–51 years.13,15–18 Had we restricted our sample to participants aged 35 and older, the data set would have shown an elevation in participants with violent behaviour and would have resembled most postmortem data sets of participants who died by violent means. The second explanation seems less likely because Pandey and colleagues52 reported an elevation in prefrontal cortex 5-HT2A receptor expression in teenaged suicide victims.
The results of this study further support the argument that elevated 5-HT2A receptor density is a diagnostic and treatment-specific phenomenon rather than a suicide-specific phenomenon. The specific cortex 5-HT2A abnormality found in medication-free people with violent behaviour differs from that found in other diagnostic-specific studies of cortex 5-HT2A receptors. Relatively recent studies demonstrate other diagnostic-specific changes in indices of prefrontal cortex 5-HT2A density, including elevations in suicide completers who suffered from depression,18,27 elevations in individuals with depression and severe pessimism,20,46 reductions of mild-to-large magnitude in treated and recently treated individuals with depression25,28,53 and no change in 5-HT2A receptor density in elderly individuals with depression54 or in individuals with borderline personality disorder, suicidal ideation and a history of severe suicide attempts.20 In particular, because it is often assumed that the underlying neurobiology of borderline personality disorder and externally focused aggression are similar, it is notable that the age-related decline in prefrontal cortex 5-HT2A receptor BPND did not differ between individuals with borderline personality disorder and healthy control participants in a study using the identical radiotracer and PET scanner.20
Further research is needed to understand why cortex 5-HT2A BPND is lower around age 20 years and why lower cortex 5-HT2A BPND declines more slowly in people with violent behaviour. A possible explanation is that there is a different rate of survival and loss of neurons containing 5-HT2A in people with violent behaviour. Cortex 5-HT2A receptors decline considerably from age 20 to 40 years, and then this decline levels off.13,15–18,20,25,27 Most 5-HT2A receptors are found in dendrites of pyramidal cell neurons,55 which also decline considerably in density from age 20 to 40 years, with the decline again tending to level off thereafter.56 It may be that, in people with violent behaviour, a neuronal cell type that contains 5-HT2A receptors such as pyramidal cell neurons has lower density early in life and a different survival duration, with the yearly rate of loss of these neurons being slower and reflected in the observed different age-related changes in cortex 5-HT2A BPND. Other explanations could include differential expression of 5-HT2A receptors in other cell types over the lifespan55,57,58 or more extracellular 5-HT at a young age.
Reconsidering the traditional interpretation that prefrontal 5-HT is low in humans with aggressive behaviour (and antisocial personality disorder and/or conduct disorder) is clinically important because the low 5-HT theory of aggression is used to argue for treatment with selective serotonin reuptake inhibitors (SSRI) for aggression in people with antisocial personality disorder and/or conduct disorder. If it is unlikely that extracellular 5-HT is low in people with violent behaviour and these diagnoses, the use of SSRIs to voluntarily reduce violent behaviour in people with these diagnoses should be based on the empirical evidence of clinical trials. Only one double-blind, placebo-controlled trial is cited to argue for treatment of agression with SSRIs in antisocial personality disorder and/or conduct disorder.59 That clinical trial shows relevance for agression in borderline personality disorder. However, it is important to note that only 10% of the participants in that clinical trial met criteria for antisocial personality disorder (conduct disorder was not discussed). Therefore, the use of SSRIs to reduce violent aggressive behaviour in humans with antisocial personality disorder and/or conduct disorder should be viewed cautiously until placebo-controlled studies focusing on these specific syndromes are completed. We are not aware of a double-blind, placebo-controlled study of the use of SSRIs for the treatment of aggression in individuals with antisocial personality disorder.
This was the first study of brain 5-HT2A receptors in people with violent behaviour toward others. We found that cortex 5-HT2A BPND was lower near age 20 years and higher near age 40 compared with healthy control participants. We also found that greater severity of impulsive behaviour correlated strongly with lower cortex 5-HT2A BPND. Low cortex 5-HT2A BPND is relevant to violent behaviour because it is most evident in those with more severely impulsive behaviour and because it occurs around age 20 years, when violent behaviour is more frequent in people with antisocial personality disorder and conduct disorder. These findings indicate that the hypothesis of low extracellular 5-HT and elevated 5-HT2A density in the cortex of people with violent behaviour must be reconsidered. They support alternative neurochemical models of violent aggression, such as decreased 5-HT turnover or general neuronal loss at an early age. These findings also suggest that abnormalities of cortex 5-HT2A receptors should be viewed as specific to particular mental disorders18,20,27 rather than to suicide itself. The findings of the present study make the hypothesis of low extracellular 5-HT in people displaying violent aggression unlikely, and therefore, the clinical practice of SSRI treatment to reduce violent behaviour in people with antisocial personality disorder or conduct disorder should be viewed with considerable caution because clinical trial data are not available.59
Acknowledgments
This research received project support from the Canadian Institutes of Health Research. We thank technician Alvina Ng and engineers Terry Bell and Ted Brandts-Harris for their assistance with this project.
Footnotes
Contributors: Drs. Meyer, Wilson and Arrowood designed the study. Drs. Meyer, Wilson, Houle, Woodside and Colleton and Ms. Martin acquired the data, which Drs. Meyer, Rusjan and Houle, Mr. Clark and Ms. Martin analyzed. Drs. Meyer, Rusjan, Houle, Arrowood, Colleton and Ms. Martin wrote the article, which Drs. Meyer, Wilson, Houle and Woodside and Mr. Clark reviewed. All authors provided final approval for publication.
Competing interests: Dr. Meyer has received operating grant support from Eli Lilly Canada, GlaxoSmithKline and Lundbeck. This project was not funded by these companies nor were any of these companies involved in any aspect of this project.
Correspondence to: Dr. J.H. Meyer, Centre for Addiction and Mental Health—College St. Site, PET Centre, 250 College St., Toronto ON M5T 1R8; jeff.meyer@camhpet.ca
References
- 1.Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation—a possible prelude to violence. Science 2000;289:591-4. [DOI] [PubMed]
- 2.Raine A, Lencz T, Bihrle S, et al. Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 2000;57:119-27; discussion 128-9. [DOI] [PubMed]
- 3.Siever LJ, Buchsbaum MS, New AS, et al. d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 1999;20:413-23. [DOI] [PubMed]
- 4.Bechara A, Damasio H, Damasio AR. Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 2000;10:295-307. [DOI] [PubMed]
- 5.Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976;33:1193-7. [DOI] [PubMed]
- 6.Träskman L, Asberg M, Sertillson L, et al. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981;38:631-6. [DOI] [PubMed]
- 7.Brown GL, Ebert MH, Goyer PF, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982;139:741-6. [DOI] [PubMed]
- 8.Caspi A, McClay J, Moffitt TE, et al. Role of genotype in the cycle of violence in maltreated children. Science 2002;297:851-4. [DOI] [PubMed]
- 9.Roth BL, McLean S, Zhu XZ, et al. Characterization of two [3H]ketanserin recognition sites in rat striatum. J Neurochem 1987;49:1833-8. [DOI] [PubMed]
- 10.Stockmeier C, Kellar K. In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci 1986;38:117-27. [DOI] [PubMed]
- 11.O'Regan D, Kwok RP, Yu PH, et al. A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition. Psychopharmacology (Berl) 1987;92:42-7. [DOI] [PubMed]
- 12.Todd KG, McManus DJ, Baker GB. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain. Cell Mol Neurobiol 1995;15:361-70. [DOI] [PMC free article] [PubMed]
- 13.Arora RC, Meltzer HY. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989;146:730-6. [DOI] [PubMed]
- 14.Mann J, Underwood M, Arango V. Postmortem studies of suicide victims. In: Watson SJ, editor. Biology of schizophrenia and affective disorders. Washington: American Psychiatric Press; 1996. p. 197-221.
- 15.Stanley M, Mann JJ. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983;1:214-6. [DOI] [PubMed]
- 16.Mann JJ, Stanley M, McBride PA, et al. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 1986;43:954-9. [DOI] [PubMed]
- 17.Arango V, Ernsberger P, Marzuk PM, et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990;47:1038-47. [DOI] [PubMed]
- 18.Hrdina PD, Demeter E, Vu TB, et al. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993;614:37-44. [DOI] [PubMed]
- 19.Dumais A, Lesage AD, Lalovic A, et al. Is violent method of suicide a behavioral marker of lifetime aggression? Am J Psychiatry 2005;162:1375-8. [DOI] [PubMed]
- 20.Meyer JH, McMain S, Kennedy SH, et al. Dysfunctional attitudes and 5-HT(2) receptors during depression and self-harm. Am J Psychiatry 2003;160:90-9. [DOI] [PubMed]
- 21.Frankle WG, Lombardo I, New AS, et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005;162:915-23. [DOI] [PubMed]
- 22.Leyton M, Okazawa H, Diksic M, et al. Brain regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 2001;158:775-82. [DOI] [PubMed]
- 23.Sekine Y, Ouchi Y, Takei N, et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 2006;63:90-100. [DOI] [PubMed]
- 24.Oquendo MA, Russo SA, Underwood MD, et al. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry 2006;59:235-43. [DOI] [PubMed]
- 25.Meyer JH, Kapur S, Eisfeld B, et al. The effect of paroxetine upon 5-HT(2A) receptors in depression: an [18(F)]setoperone PET imaging study. Am J Psychiatry 2001;158:78-85. [DOI] [PubMed]
- 26.Stockmeier CA. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 2003;37:357-73. [DOI] [PubMed]
- 27.Yates M, Leake A, Candy JM, et al. 5HT2 receptor changes in major depression. Biol Psychiatry 1990;27:489-96. [DOI] [PubMed]
- 28.Yatham LN, Liddle PF, Dennie J, et al. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry 1999;56:705-11. [DOI] [PubMed]
- 29.Maziere B, Crouzel C, Venet M, et al. Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors. Int J Rad Appl Instrum B 1988;15:463-8. [DOI] [PubMed]
- 30.Petit-Taboué MC, Landeau B, Osmont A, et al. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis. J Nucl Med 1996;37:95-104. [PubMed]
- 31.Fischman AJ, Bonab AA, Babich JW, et al. Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent ziprasidone. J Pharmacol Exp Ther 1996;279:939-47. [PubMed]
- 32.Meyer JH, Kapur S, Houle S, et al. Prefrontal cortex 5-HT2 receptors in depression: an [18(F)]setoperone PET imaging dtudy. Am J Psychiatry 1999;156:1029-34. [DOI] [PubMed]
- 33.Schmuck K, Ullmer C, Engels P, et al. Cloning and functional characterization of the human 5-HT2B serotonin receptor. FEBS Lett 1994;342:85-90. [DOI] [PubMed]
- 34.Hoyer D, Pazos A, Probst A, et al. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 1986;376:97-107. [DOI] [PubMed]
- 35.First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 1995.
- 36.Blais MA, Norman DK. A psychometric evaluation of the DSM-IV personality disorder criteria. J Personal Disord 1997;11:168-76. [DOI] [PubMed]
- 37.Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979;47:343-52. [DOI] [PubMed]
- 38.Patton JH, Stanford M, Barratt E. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995;51:768-74. [DOI] [PubMed]
- 39.Biaggio MK, Supplee K, Curtis N. Reliability and validity of four anger scales. J Pers Assess 1981;45:639-48. [DOI] [PubMed]
- 40.Ichise M, Liow JS, Lu JQ, et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003;23:1096-112. [DOI] [PubMed]
- 41.Kapur S, Jones C, DaSilva J, et al. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging. Nucl Med Commun 1997;18:395-9. [DOI] [PubMed]
- 42.Logan J, Fowler JS, Volkow ND, et al. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-40. [DOI] [PubMed]
- 43.Turecki G, Brière R, Dewar K, et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999;156:1456-8. [DOI] [PubMed]
- 44.New AS, Hazlett EA, Buchsbaum MS, et al. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry 2002;59:621-9. [DOI] [PubMed]
- 45.Bencherif B, Stumpf MJ, Links JM, et al. Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. J Nucl Med 2004;45:402-8. [PubMed]
- 46.Bhagwagar Z, Hinz R, Taylor M, et al. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am J Psychiatry 2006;163:1580-7. [DOI] [PubMed]
- 47.Moffitt TE, Caspi A. Life-course persistent and adolescence-limited antisocial males: longitudinal followup to adulthood. In: Stoff D, Susman E, editors. Developmental psychobiology of aggression. New York: Cambridge University Press; 2005. p. 161-86.
- 48.Weisstaub NV, Zhou M, Lira A, et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006;313:536-40. [DOI] [PubMed]
- 49.Palmer AM, Sims NR, Bowen DM, et al. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry 1984;47:481-4. [DOI] [PMC free article] [PubMed]
- 50.Wallin A, Blennow K, Edman A, et al. Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia. Int Psychogeriatr 1996;8:425-36. [DOI] [PubMed]
- 51.Yang Y, Raine A, Lencz T, et al. Volume reduction in prefrontal gray matter in unsuccessful criminal psychopaths. Biol Psychiatry 2005;57:1103-8. [DOI] [PubMed]
- 52.Pandey GN, Dwivedi Y, Rizavi HS, et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002;159:419-29. [DOI] [PubMed]
- 53.Yatham LN, Liddle PF, Shiah IS, et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry 2000;57:850-8. [DOI] [PubMed]
- 54.Meltzer CC, Price JC, Mathis CA, et al. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry 1999;156:1871-8. [DOI] [PubMed]
- 55.Jakab RL, Goldman-Rakic PS. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A 1998;95:735-40. [DOI] [PMC free article] [PubMed]
- 56.Jacobs B, Driscoll L, Schall M. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J Comp Neurol 1997;386:661-80. [PubMed]
- 57.Santana N, Bortolozzi A, Serrats J, et al. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 2004;14:1100-9. [DOI] [PubMed]
- 58.Wu C, Singh SK, Dias P, et al. Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Exp Neurol 1999;158:529-33. [DOI] [PubMed]
- 59.Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997;54:1081-8. [DOI] [PubMed]




